| 000 | 01729 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516050203.0 | ||
| 264 | 0 | _c20120328 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1555-8576 | ||
| 024 | 7 |
_a10.4161/cbt.12.7.16302 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Ying | |
| 245 | 0 | 0 |
_aEffects of IL-17A on the occurrence of lung adenocarcinoma. _h[electronic resource] |
| 260 |
_bCancer biology & therapy _cOct 2011 |
||
| 300 |
_a610-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdenocarcinoma of Lung |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCD4 Antigens _xmetabolism |
| 650 | 0 | 4 |
_aCD8 Antigens _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-17 _xblood |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xchemically induced |
| 650 | 0 | 4 |
_aReceptors, Interleukin-17 _xmetabolism |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 700 | 1 | _aCao, Zhen Yuan | |
| 700 | 1 | _aSun, Bo | |
| 700 | 1 | _aWang, Guang You | |
| 700 | 1 | _aFu, Zheng | |
| 700 | 1 | _aLiu, Yu Mei | |
| 700 | 1 | _aKong, Qing Fei | |
| 700 | 1 | _aWang, Jing Hua | |
| 700 | 1 | _aZhang, Yao | |
| 700 | 1 | _aXu, Xiang Ying | |
| 700 | 1 | _aLi, Hu Lun | |
| 773 | 0 |
_tCancer biology & therapy _gvol. 12 _gno. 7 _gp. 610-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cbt.12.7.16302 _zAvailable from publisher's website |
| 999 |
_c21032015 _d21032015 |
||